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Abstract. 
 
Mice lacking the AP-1 transcription factor
c-Jun die around embryonic day E13.0 but little is 
known about the cell types affected as well as the cause 
of embryonic lethality. Here we show that a fraction of 
mutant E13.0 fetal livers exhibits extensive apoptosis of 
both hematopoietic cells and hepatoblasts, whereas the 
expression of 15 mRNAs, including those of albumin, 
 
keratin 18, hepatocyte nuclear factor 1, 
 
b
 
-globin, and 
erythropoietin, some of which are putative AP-1 target 
genes, is not affected. Apoptosis of hematopoietic cells 
in mutant livers is most likely not due to a cell-autono-
 
mous defect, since 
 
c-jun
 
2
 
/
 
2
 
 fetal liver cells are able to 
reconstitute all hematopoietic compartments of lethally 
irradiated recipient mice. A developmental analysis of 
chimeras showed contribution of 
 
c-jun
 
2
 
/
 
2
 
 ES cell deriv-
atives to fetal, but not to adult livers, suggesting a role 
of c-Jun in hepatocyte turnover. This is in agreement 
with the reduced mitotic and increased apoptotic rates 
 
found in primary liver cell cultures derived from 
 
c-jun
 
2
 
/
 
2
 
 
fetuses. Furthermore, a novel function for c-Jun was 
found in heart development. The heart outﬂow tract of 
 
c-jun
 
2
 
/
 
2
 
 
 
fetuses show malformations that resemble the 
human disease of a truncus arteriosus persistens. There-
fore, the lethality of 
 
c-jun
 
 mutant fetuses is most likely 
due to pleiotropic defects reﬂecting the diversity of 
functions of c-Jun in development, such as a role in 
neural crest cell function, in the maintenance of hepatic 
hematopoiesis and in the regulation of apoptosis.
Key words: apoptosis • neural crest • hematopoiesis • 
knockout • truncus arteriosus persistens
 
T
 
HE
 
 proto-oncogene 
 
c-jun
 
 encodes a component of
the transcription factor AP-1 (activating protein 1)
 
1
 
,
which has been implicated in the regulation of di-
verse cellular functions, such as proliferation, differentia-
tion, transformation, and apoptosis. AP-1 is a dimer con-
sisting of different subunits, e.g., proteins of the Jun (c-Jun,
JunB, and JunD) and Fos (c-Fos, FosB, Fra1, and Fra2)
family as well as CREB/ATF, and Maf proteins. The dif-
ferent AP-1 components are expressed in a development-
and tissue-specific manner, implying that AP-1 composed
of different subunits may exert different functions in dif-
ferent cell types. Although AP-1 was found to regulate a
few genes, such as human metallothionein IIA (Lee et al.,
1987), collagenase (Angel et al., 1987), stromelysin (Kerr
et al., 1988), and keratin 18 (Oshima et al., 1990), the bio-
logical function of the different AP-1 complexes during
development is still elusive. The characterization of the
role of AP-1 is further impeded by the fact that there are,
in addition to the variability in subunit composition, nu-
merous possible interactions between AP-1 and other
transcription factors, such as glucocorticoid hormone re-
ceptors (Jonat et al., 1990), estrogen receptors (Gaub et
al., 1990), retinoic acid and vitamin D3 receptors (Schüle
et al., 1990), and MyoD (Bengal et al., 1992) yielding a net-
work of transcriptional regulation.
First clues on tissue-specific functions of AP-1 compo-
nents came from gene knockout experiments. In 
 
c-fos
 
knockout mice the development of bone is impaired be-
cause of a block in osteoclast differentiation (Grigoriadis
et al., 1994). Moreover, lymphoid cells, germ cells, and
neuronal tissues are affected in the absence of c-Fos
(Johnson et al., 1992; Wang et al., 1992). In contrast to the
inactivation of 
 
c-fos
 
, targeted disruption of 
 
c-jun
 
 and 
 
junB
 
is lethal (Hilberg et al., 1993; Johnson et al., 1993;
Schorpp-Kistner et al., 1999). Lethality of 
 
c-jun
 
2
 
/
 
2
 
 fetuses
has been suggested to be due to defective liver develop-
ment. The livers of some E12.5 animals appeared hypo-
plastic with rounded, dissociated hepatoblasts showing
features of apoptosis and necrosis. Moreover, increased
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numbers of erythropoietic cells were noted in these livers
(Hilberg et al., 1993). A defect in hepatogenesis in c-Jun
knockout mice was further indicated by the observation
that 
 
c-jun
 
2
 
/
 
2
 
 embryonic stem (ES) cells failed to contrib-
ute to the liver but not to other tissues of adult chimeric
mice (Hilberg et al., 1993). These observations, together
with the fact that no morphological alterations were found
in organs other than the liver, led to the conclusion that
the absence of c-Jun might preferentially affect the devel-
opment of the liver (Hilberg et al., 1993).
In the mouse, liver development starts at around E9.5
when epithelial cells of the foregut endoderm proliferate
and invade the mesenchyme of the septum transversum
thus forming the embryonic liver. At around E11 hemato-
poietic stem and progenitor cells derived from the yolk sac
and aorta-gonad-mesonephros region colonize the liver,
and the liver becomes the major hematopoietic organ dur-
ing further fetal development (Dzierzak and Medvinsky,
1995). To allow establishment and maintenance of he-
matopoiesis, liver cells have to provide the proper mi-
croenvironment for hematopoietic cells comparable to
stromal cells in the bone marrow during postnatal life. The
next major step in mouse liver development occurs at ap-
proximately E14.5 when hepatoblasts start to differentiate
into the hepatocytic and bile duct epithelial lineage, which
is indicated by the formation of the ductal plate, which
later differentiates into the intrahepatic bile ducts (Des-
met, 1998). It is as yet unclear at which developmental
stage c-Jun becomes essential for the liver, and whether
the defect is restricted to the hepatocytic lineage or other
cell types of the fetal liver, such as bile duct epithelia, en-
dothelial cells, stellate cells (vitamin A–storing cells),
Kupffer cells, and hematopoietic cells.
Besides the poorly characterized function in liver devel-
opment, c-Jun plays a more general role in the regulation
of cell proliferation and apoptosis. It has been shown in fi-
broblasts isolated from E11.5 
 
c-jun
 
2
 
/
 
2
 
 and 
 
c-jun
 
1
 
/
 
2
 
 em-
bryos that the absence or diminished expression of c-Jun
resulted in greatly reduced growth rates, and that this pro-
liferation defect could not be compensated by addition of
purified mitogens (Johnson et al., 1993; Schreiber et al.,
1999). Evidence for a role of c-Jun and c-Jun phosphoryla-
tion in apoptosis was obtained in neuronal cells where
transient overexpression of c-Jun induced apoptosis, and
expression of a dominant negative 
 
c-jun
 
 mutant inhibited
apoptosis in vitro (Estus et al., 1994; Ham et al., 1995; Beh-
rens et al., 1999). In vivo, however, c-Jun was regarded not
to be essential for apoptosis since in the developing mouse
(E11.5 
 
c-jun
 
2
 
/
 
2
 
 fetuses) the physiologically occurring apop-
tosis appeared unaffected (Roffler-Tarlov et al., 1996).
The different phenotypes observed in the various AP-1
knockout mice point to cell type– and developmental-spe-
cific roles of AP-1 complexes. The biological basis for the
specific roles is not yet understood. To gain more insight
into how the absence of a widely expressed transcription
factor like c-Jun affects the liver, and to see whether other
tissues are affected, we investigated in detail the morpho-
logical and functional alterations in 
 
c-jun
 
 knockout mice
as well as the distribution of 
 
c-jun
 
2
 
/
 
2
 
 cells in chimeric mice
at various stages during fetal development and postnatal
life. A deregulation of apoptosis was found in a variety of
cell types lacking 
 
c-jun
 
, such as hepatoblasts, erythroid
 
cells, and fibroblasts. In contrast to previous reports that
suggested that c-Jun is essential for cells to undergo apop-
tosis, we observed markedly increased apoptotic rates in
the absence of c-Jun. It is possible that an increased sus-
ceptibility of cells to apoptosis was responsible for the
morphologic alterations seen in the livers of 
 
c-jun
 
2
 
/
 
2
 
 mice.
Increased apoptotic rates in combination with reduced
proliferation rates would result in a disturbance of hepato-
cyte turnover which could explain the absence of 
 
c-jun
 
2
 
/
 
2
 
hepatocytes in livers of adult chimeric mice. Furthermore,
a novel function of c-Jun in heart development was identi-
fied, since all 
 
c-jun
 
2
 
/
 
2
 
 fetuses had a malformation of the
outflow tract of the heart which could be a contributing
factor to the fetal lethality.
 
Materials and Methods
 
Mice
 
Heterozygous 
 
c-jun
 
1
 
/
 
2
 
 male and female mice of C57BL/129 background
(Hilberg et al., 1993) were mated and the appearance of the vaginal plug
was taken as E0.5. Pregnant mothers were killed at 11.5–14.5 d of gesta-
tion by cervical dislocation and the fetuses were isolated. Genotypes of fe-
tuses were determined by PCR using the primers c-jun 1430 and c-jun
2287 (Table I).
 
Morphologic and Immunohistochemical Analysis
of Fetuses
 
Mouse fetuses were fixed in 10% phosphate-buffered formaldehyde, par-
affin-embedded, and then 4-
 
m
 
m sections were stained with hematoxylin-
eosin (HE).
Apoptotic cells were analyzed in paraffin sections by in situ DNA end
labeling (TUNEL; Sibilia et al., 1998), and labeled DNA was detected
with the ABC procedure (DAKO).
For double-label immunofluorescence analysis fetuses were snap-fro-
zen in isopentane at the temperature of liquid nitrogen, and sections (4 
 
m
 
m
thick, fixed in acetone at 
 
2
 
20
 
8
 
C for 10 min) were sequentially incubated
with the following antibodies: monoclonal mouse antibodies against
desmoplakin I and II (Boehringer Mannheim), E-cadherin (ZYMED),
connexin 43 (Cx 43; Transduction Laboratories), and monoclonal rat anti-
bodies TER119, CD71, CD11b, and CD34 (PharMingen) against hemato-
poietic cells or polyclonal rabbit antibodies against desmin (Chemicon)
or keratins 8 and 18 (Zatloukal et al., 1990). Primary antibodies were
detected with fluorescein isothiocyanate-conjugated or tetramethyl-
rhodamine isothiocyanate-conjugated antibodies directed against mouse
and rat or rabbit immunoglobulins, respectively. For negative control, pri-
mary antibodies were omitted or replaced by unrelated isotype-matched
immunoglobulins. Specimens were analyzed with a MRC600 (Bio Rad
Laboratories) laser-scanning confocal device attached to a Zeiss Axiophot
microscope. Alternatively, sections of paraffin-embedded liver samples
were stained with the antibodies to keratins 8 and 18 or the antibody
TER119 after pretreatment with pronase E, and bound antibodies were
detected by the APAAP procedure (DAKO).
 
Reconstitution of Hematopoiesis in Lethally Irradiated 
Mice and Flow Cytometric Analysis of Blood Cells
 
Liver cells isolated from C57BL/129 E12.5 
 
c-jun
 
1
 
/
 
2
 
 and 
 
c-jun
 
2
 
/
 
2
 
 fetuses
were resuspended in PBS, and 10
 
6
 
 cells were injected intravenously into
adult C57BL/129 wild-type recipient mice that were lethally irradiated
(9.5 Gy). All control mice injected with PBS died after 2 wk. After 8 mo, re-
constitution of the various hematopoietic lineages was analyzed by FAC-
Scan
 
®
 
 with the following cell surface markers: B220, CD43, GR1, MAC1,
CD4, CD8, TER119, and HSA as described (Sibilia and Wagner, 1995).
 
Quantitative RT-PCR
 
For generation of exogenous artificial RNA standards that served as com-
petitors in quantitative RT-PCR, sequences corresponding to the mRNA
or heterologous (unrelated) sequences were cloned into the expression 
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vector pCRII (Invitrogen; Table I). For restriction standards, a cleavage
site of a restriction enzyme between the primer binding sites was mutated
by filling it with Klenow fragment (Promega Corp.). Standard plasmids
with a deletion between the primer binding sites were constructed either
by Bal 31 exonuclease digest or by loop out mutagenesis. For heterolo-
gous standards, a heterologous sequence, flanked by the specific primer
binding sequences, was generated by amplification with hybrid primers
and cloned into pCRII. Exogenous artificial RNA transcripts were gener-
ated from linearized standard plasmids by in vitro transcription with the
corresponding RNA polymerases (T3, T7, and SP6 were obtained from
Boehringer Mannheim). First strand cDNA synthesis for quantitative RT-
PCR was performed in a 20-
 
m
 
l reaction mixture containing 0.1 
 
m
 
g of total
RNA (isolated as described by Krieg et al., 1983), 0.5 units Inhibit-ACE
(5
 
9
 
®
 
3
 
9
 
 Inc.), 1
 
3
 
AMV reverse transcription buffer (100 mM Tris-HCl, pH
8.3 at 42
 
8
 
C, 40 mM KCl, 10 mM MgCl
 
2
 
, and 0.5 mM spermidine), 5 mM
dNTPs (1.25 mM each), 4 mM sodium pyrophosphate, 5 units AMV re-
verse transcriptase (Boehringer Mannheim), 0.5 
 
m
 
M lower primer, and a
certain number of exogenous artificial RNA molecules. For PCR optimal
buffers for each primer pair were selected using the PCR optimizer kit
(Invitrogen; Table I). PCR was performed with one-tenth of the cDNA
products amplified in a 50-
 
m
 
l reaction containing 1
 
3
 
 PCR buffer, 5 
 
m
 
l
DMSO, 1 
 
m
 
M of each primer (except 0.5 
 
m
 
M for quantitation of hepato-
cyte growth factor mRNA), 0.25 
 
m
 
M of each dNTP, and 2.5 units Ampli-
Taq DNA Polymerase (Perkin Elmer Cetus). The reaction was heated to
94
 
8
 
C, then Taq Polymerase was added, and subsequently cycled for 45 cy-
cles at 94
 
8
 
C, 1 min, 55
 
8
 
C (except 50
 
8
 
C for albumin and transferrin, 52
 
8
 
C
for erythropoietin), 1 min, and 72
 
8
 
C, 1 min. At the end of the last cycle a
final extension step of 4 min at 72
 
8
 
C was added. PCR products were sepa-
rated on ethidium bromide-stained agarose gels and band intensities were
estimated by video densitometry (Docu Gel V densitometer and Rflp-
Scan or ONE-Dscan software; Scanalytics). mRNA copy numbers were
calculated from the differences in the band intensities which were cor-
rected by application of standard curves as described (Eferl et al., 1997).
 
Analysis of Chimeric Mice
 
c-jun
 
2
 
/
 
2
 
 ES cells (clone D3-2, Hilberg et al., 1993) were injected into
C57BL/6 blastocysts. Tissues of chimeric mice were analyzed for glucose
phosphate isomerase (GPI) isoenzyme distribution as described (Hilberg
et al., 1993). The contribution of 
 
c-jun
 
2
 
/
 
2
 
 ES cells to fetal liver tissue was
analyzed in short-term cultures of fetal liver cells. Fetal livers were dis-
sected from staged fetuses and after a brief rinse in PBS subjected to 5-min
subsequent incubations in solution A (EBSS without Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
 con-
taining 0.5 mM EGTA), solution B (EBSS containing Ca
 
2
 
1
 
, Mg
 
2
 
1
 
, and 10
 
mM Hepes, pH 7.4), and solution C (EBSS containing Ca
 
2
 
1
 
, Mg
 
2
 
1
 
, 10 mM
Hepes, pH 7.4, and 0.3 mg/ml collagenase). Fetal livers were washed once
in PBS and liver cells were dispersed by pipetting several times with a 1-ml
glass pipette. After centrifugation, cells were cultured in plastic dishes
(Falcon Primaria, Becton Dickinson) in DMEM containing 10% fetal calf
serum for 2–3 d and nonadherent hematopoietic cells were removed by
repeated washings twice daily. GPI analysis was then performed with cul-
tured fetal liver cells and with the residual fetal tissues, which remained af-
ter dissection of the liver, to calculate the relative contribution of 
 
c-jun
 
2
 
/
 
2
 
ES cells to the liver in relation to the average chimerism.
The contribution of 
 
c-jun
 
2
 
/
 
2
 
 ES cells to the various tissues of chimeric
mice at various age after birth was furthermore determined by PCR using
the primers c-jun 1430 and c-jun 2287 (Table I). Hepatocytes were iso-
lated from livers of 8-wk-old chimeric mice by collagenase liver perfusion
essentially as described by Seglen (1976) except that perfusion was per-
formed via the left ventricle (Edström et al., 1983). This technique yields a
hepatocyte preparation with 
 
z
 
90% purity (as estimated by immunohis-
tochemical detection of keratin), and, based on trypan blue exclusion,
 
.
 
85% viability. For preparation of bile ducts, sections of snap-frozen liv-
ers were stained with methylene blue, and bile ducts were microdissected
under a stereo-microscope using a 25-G needle attached to an 1-ml sy-
ringe. The microdissected tissue was collected in an Eppendorf tube and
DNA was isolated for PCR analysis. PCR products were separated on
ethidium bromide–stained agarose gels and band intensities were esti-
mated by video densitometry. Nonlinearity of band intensity ratios was
corrected with a standard curve (Eferl et al., 1997).
 
Simultaneous Detection of S-Phase Cells and Apoptotic 
Cells in Fetal Liver Cell Cultures
 
Livers from E12.5 mouse fetuses were mechanically dissociated and
plated onto plastic chamber slides (NUNC, Kamstrup, DK) in DME
containing 10% FCS. Liver cells were cultured for 2 wk in order to re-
move hematopoietic cells. Purity of cultured hepatoblasts was controlled
by keratin immunostaining using rabbit antibodies to keratins 8 and 18,
showing that more than 95% of the cells were keratin positive. Primary fi-
broblasts from E12.5 fetuses were cultured as described (Robertson,
1987). [
 
3
 
H]thymidine labeling was performed with 300 kBq methyl
[
 
3
 
H]thymidine/ml medium (Amersham). Primary hepatocytes were la-
beled for 2 h, fibroblasts for 1 h at 37
 
8
 
C followed by an incubation step in
medium without [
 
3
 
H]thymidine for 30 min. Thereafter cells were rinsed
twice with medium and PBS and fixed with 4% paraformaldehyde in PBS,
pH 7.4, for 30 min at room temperature. Apoptotic cells were stained with
the in situ cell death detection kit (Boehringer Mannheim). After dehy-
 
Table I. Artificial RNA Standards and Primers for Quantitative RT-PCR
 
mRNA Standard sequence Upper primer Lower primer Buffer Reference
 
Albumin 391-584; NcoI (215) 391-407 568-584 K Minghetti et al., 1985
Transferrin 750 bp of 3
 
9
 
 end in vector 5
 
9
 
-TCA ACC TCA 5
 
9
 
-GCA GCG AAG A Ruppert et al., 1990
pmTF-2; NcoI CGA CTC CT-3
 
9
 
ACT ACA CC-3
 
9
 
Keratin 8 1299-3
 
9
 
-end; d1317 1348 1299-1316 1439-1456 F Morita et al., 1988
Keratin 18 904-3
 
9
 
-end; d921-952 904-920 1023-1040 F Singer et al., 1986
HNF-1 1122-1997; AocI (1715) 1494-1511 1765-1782 J Kuo et al., 1990
 
b
 
-Globin pGEM3Zf (1357-1550) 38390-38407 39436-39453 N Shehee et al., 1989
 
e
 
-Globin pGEM3Zf (1357-1550) 9625-9642 10482-10499 N Shehee et al., 1989
Erythropoietin 1239-3201; AccI (2365) 1303-1320 3149-3166 N Shoemaker et al., 1986
c-jun 1430-1492/811 bp neo/2205-2304 1430-1447 2287-2304 A Ryder and Nathans, 1988
junB 1081-1483; d1249-1332 1081-1098 1466-1483 J Ryder et al., 1988
junD pGEM3Zf (1132-1275) 519-535 732-748 N Ryder et al., 1989
c-fos 2969-3574; AccI (3220) 2969-2992 3551-3574 J van Beveren et al., 1983
fosB 6379-6830; d6418-6592 6397-6414 6813-6830 J Lazo et al., 1992
c-myc 969-1407; d1003-1186 969-986 1390-1407 J Stanton et al., 1984
Cyclin D2 55-520; d228-293 55-76 502-520 F Matsushime et al., 1991
Hepatocyte growth factor 1186-1748; d1384-1595 1186-1203 1731-1748 B Liu et al., 1993
Glyceraldehyde-3-phosphate 326-1152; CelII (510) 428-445 787-804 L Sabath et al., 1990
dehydrogenase
 
Bp numbering corresponds to the published cDNA or genomic DNA sequences. Restriction enzymes used for generation of standards with a mutated restriction site, the positions
of the deletions in deletion standards (d) and the positions of the heterologous sequences on plasmid pGEM3z, amplified for heterologous standards, are indicated. In the case of
the heterologous standard for 
 
c-jun
 
, a part of the 
 
c-jun
 
 sequence between bp 1492 and 2205 is replaced by the neomycin resistance gene sequence of transposon TN5 (Hilberg et al.,
1993). The indicated buffers correspond to the various PCR buffers of the PCR optimizer kit (Invitrogen). 
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dration with increasing concentrations of ethanol [
 
3
 
H]thymidine-labeled
cells were visualized with Kodak NTB2 photoemulsion and detected with
Kodak D19 developer.
 
Results
 
Apoptosis of Hepatoblasts and Erythroid Cells in Fetal 
Livers Lacking c-jun
 
Previous studies revealed no readily detectable differences
in development or morphology between wild-type and
 
c-jun
 
2
 
/
 
2
 
 fetuses at least up to E11.5 (Johnson et al., 1993;
Hilberg et al., 1993). Between E11.5 and E14.5, in some
 
c-jun
 
2
 
/
 
2
 
 fetuses rounded hepatoblasts, which were de-
tached from each other and scattered cells with character-
istic features of apoptosis and necrosis, were detected (Hil-
berg et al., 1993). However, the cell types that are affected
primarily in the absence of c-Jun had not been determined
yet and the developmental stage at which c-Jun becomes
essential for liver development was unclear. To address
these questions, detailed histological analyses of fetal liv-
ers from E12.5 and E13.0 
 
c-jun
 
2
 
/
 
2
 
 fetuses were performed.
Figure 1. Apoptosis and dis-
tribution of hepato- and
erythropoiesis in livers of
c-jun2/2 mouse fetuses. Liver
sections of E13.0 wild-type
(1/1, A and C) and homozy-
gous  c-jun knockout (2/2, B
and D–F) littermates. The
HE-stained sections (A and
B) show numerous cells with
condensed nuclei, typical for
apoptotic cells (arrowheads
in B) in c-jun2/2 livers. These
nuclei contain fragmented
DNA, as demonstrated by
TUNEL staining (C and D,
arrowheads in D). The cell
types that undergo apoptosis
were characterized using
rabbit antibodies to keratins
8/18 (E) and the monoclonal
rat antibody TER119 (F), re-
spectively. Bound antibod-
ies were detected by the
APAAP procedure and sec-
tions were counterstained
with HE. In E hepatoblasts
with fragmented nuclei
(filled arrowheads) and hepa-
toblasts with intact nuclei are
visible. Some of the hepato-
blasts contain apoptotic bod-
ies (open arrowhead) en-
gulfed by phagocytosis. In F
TER119-positive erythroid
cells containing fragmented
nuclei are shown (arrow-
heads). Distribution of
hepatopoiesis and erythro-
poiesis in livers of E12.5
wild-type (1/1, G) and
c-jun2/2 littermates (2/2,
H). Liver sections were dou-
ble-labeled with antibodies
to hepatoblasts and erythroid
cells using rabbit antibodies
to keratins 8 and 18 (green)
and the monoclonal rat anti-
body TER119 (red), respec-
tively. Bars, 20 mm.Eferl et al. c-Jun in Liver and Heart Development 1053
At E12.5, no morphologic abnormalities were observed in
c-jun2/2 livers. At E13.0, however, 8 out of 19 c-jun2/2 fe-
tuses showed increased apoptosis in the livers when com-
pared with wild-type littermates (Fig. 1, A and B). In two
of these c-jun2/2 fetuses, apoptosis was very extensive, af-
fecting up to one-third of all liver cells. Staining by in situ
DNA end labeling (TUNEL) revealed fragmented DNA
present in the condensed nuclei of cells undergoing apop-
tosis (Fig. 1, C and D). Characterization of the affected
cell type by immunohistochemical staining with antibodies
against keratins 8 and 18, which is expressed in hepato-
blasts, and the erythroid-specific antibody TER119 con-
firmed, that condensed and fragmented nuclei typical of
early apoptosis were present in hepatoblasts and in eryth-
roid cells (Fig. 1, E and F). However, cells in advanced
stages of apoptosis could not be classified by this method.
But from the high number and distribution of apoptotic
cells it is likely that apoptosis affects hepatoblasts as well
as erythroid cells.
Until E12.5, hepatic erythropoiesis appeared normal
since immunohistological analyses of livers using the
erythroid-specific antibody TER119 (Fig. 1, G and H) and
an antibody to CD71, a marker which is present in high
amounts on erythroid cells, revealed no differences in the
number and distribution of erythroid cells between c-jun1/1
and  c-jun2/2 E12.5 fetuses. Moreover, macrophages, as
demonstrated by staining with antibody to CD11b (Mac-1)
and CD34-positive cells, were also present in comparable
amounts (data not shown). This suggests that c-Jun is not
required for proper establishment of hepatic hematopoie-
sis but rather is essential for its maintenance.
At around E11.5, the liver becomes the primary site of
hematopoiesis and liver cells are necessary to provide the
proper microenvironment to support survival of hemato-
poietic cells (Dzierzak and Medvinsky, 1995). The apopto-
sis observed in c-jun2/2 erythroblasts could either be due
to a cell-autonomous defect in this particular cell lineage
or, alternatively, c-jun2/2 fetal liver cells may be unable to
provide the proper microenvironment for hematopoietic
cells. To discriminate between these two possibilities and
in order to investigate whether c-jun2/2 hematopoietic
cells were affected in a cell-autonomous manner, E12.5
c-jun2/2 fetal liver cells were injected intravenously into
wild-type lethally irradiated syngeneic adult mice. After
six months, mice reconstituted with c-jun2/2 cells were
healthy and flow cytometric analysis of spleen, bone mar-
row, and thymus of two mice showed a similar distribu-
tion of myeloid and lymphoid cells as the controls (Fig. 2
A and data not shown). Analysis of peripheral blood
showed no significant differences in hematocrits and red
blood cell counts (data not shown). PCR analysis of ge-
nomic DNA isolated from bone marrow, spleen, and thy-
mus of the reconstituted mice confirmed that these organs
had been mostly colonized by c-jun2/2 hematopoietic cells
(Fig. 2 B). These results indicate that hematopoietic cells
of all lineages are present and functional in c-jun2/2 fetal
livers, which excludes an absolute cell-autonomous de-
fect. Therefore, the observed apoptosis in the erythroid
lineage might be caused by non–cell-autonomous alter-
ations, such as a disturbance of the microenvironment in
c-jun2/2 fetal livers which is essential to sustain hemato-
poiesis.
Lack of c-Jun Does Not Impair Fetal Liver
Gene Expression
An altered hepatic microenvironment in c-jun2/2 fetuses
Figure 2. Reconstitution of hematopoiesis in lethally irradiated
mice by c-jun2/2 cells. (A) The hematopoietic compartment of a
lethally irradiated mouse was reconstituted with c-jun1/2 (left
column) and c-jun2/2 (right column) fetal liver hematopoietic
cells and then analyzed by flow cytometry analysis of the spleen
cells. The following antibodies to cell surface markers were used:
B220 for B cells, CD43 for leukocytes, GR1 for granulocytes,
Mac1 for macrophages, CD4 and CD8 for T cells, TER119 for
erythroid cells, and heat stable antigen (HSA) for lymphoid
precursor cells. (B) PCR analysis of genomic DNA isolated from
bone marrow (bm), spleen (sp), and thymus (thy) of mice recon-
stituted with c-jun1/2 and c-jun2/2 hematopoietic cells. The geno-
type of the donor fetal liver cells is indicated above, and the
size of the PCR products, derived from mutant and wild-type al-
leles on the right side. For control, PCR was performed with
DNA from c-jun1/1 (1/1) and c-jun2/2 (2/2) mice, and without
DNA (N).The Journal of Cell Biology, Volume 145, 1999 1054
could be the consequence of deregulated gene expression
in liver cells. Therefore, we analyzed the expression pat-
terns of genes that are either known to be regulated by
AP-1 or serve as indicators for hepatoblast differentiation
and function. Since only small amounts of RNA can be ob-
tained from E12.5 livers, we established and validated a
variety of quantitative RT-PCR assays for estimation of
mRNA concentrations (Eferl et al., 1997). This technique
allowed analysis of several mRNAs in single fetal livers of
littermates. The expression of differentiation markers for
hepatoblasts, like hepatocyte nuclear factor-1 (HNF-1),
and keratins 8 and 18, as well as the expression of genes in-
volved in growth regulation, namely, the mRNAs for
hepatocyte growth factor (HGF), c-myc and cyclin D2 was
unaffected in c-jun2/2 livers (Fig. 3, A and B). Moreover,
the mRNA levels for secreted liver proteins as indicators
for liver cell function, such as serum albumin and transfer-
rin, did not differ between c-jun1/1, c-jun1/2, and c-jun2/2
livers (Fig. 3 B). To see whether the ablation of c-Jun
modified the expression of other Jun and Fos family mem-
bers in order to compensate the loss of c-Jun functions we
further analyzed the expression levels of junB, junD, c-fos,
and fosB. None of these genes revealed altered expression
in c-jun2/2 mice (Fig. 3 B).
In addition to the analysis of possible alteration of gene
expression in hepatoblasts, we investigated possible effects
of the absence of c-Jun in erythroid cell. Because at
around E12.0 there is the shift from embryonic e-globin to
adult b-globin expression, we analyzed the expression lev-
els of b-globin and e-globin mRNAs. The ratio as well as
the total mRNA concentrations for both globins were simi-
lar in wild-type, c-jun1/2 and c-jun2/2 mice (Fig. 3 B), which
is in line with the immunofluorescence data demonstrating
a proper establishment of hepatic hematopoiesis. We fur-
ther analyzed the expression of erythropoietin, which is
the most important growth and survival factor for eryth-
roid cells. The liver is expected to be the major site of
erythropoietin synthesis during late fetal development,
and decreased amounts of this factor could be responsible
for apoptosis of erythroid cells as observed in c-jun2/2 liv-
ers. (Koury et al., 1988). Using quantitative RT-PCR we
show here that erythropoietin is expressed already in
E12.5 fetal livers, although at a very low level. Further-
more, the analyses revealed no difference in the eryth-
ropoietin mRNA copy numbers between c-jun1/1 and
c-jun2/2 livers, indicating that erythropoietin synthesis is
not decreased in c-jun2/2 mice.
It is surprising that all mRNAs analyzed, including
mRNAs of genes that are known to be regulated by AP-1,
such as keratin 18 (Oshima et al., 1990) and b-globin (Ney
Figure 3. Analysis of mRNA expression in E12.5 wild-type (c-
jun1/1), heterozygous (c-jun1/2), and homozygous c-jun–deleted
(c-jun2/2) fetal livers by quantitative RT-PCR. (A) Ethidium
bromide–stained agarose gels showing quantitative RT-PCR of
hepatocyte nuclear factor 1 (HNF-1) mRNA in E12.5 fetal livers.
The amount of HNF-1 mRNA was estimated by a titration assay
with decreasing copy numbers of RNA standard molecules (indi-
cated at the top of the figure) and a constant amount of liver
RNA (0.1 mg). Cleaved PCR products (221 bp, 67 bp) are derived
from HNF-1 mRNA; noncleaved PCR products (288 bp) are de-
rived from the RNA standard. (B) Quantitative RT-PCR of
mRNAs in E12.5 fetal livers. The bars represent mean values of
mRNA copy numbers per 0.1 mg RNA of at least three indepen-
dent experiments. The standard deviations are indicated. HNF-1,
hepatocyte nuclear factor 1; EPO, erythropoietin; HGF, hepato-
cyte growth factor; GAPDH, glyceraldehyde-3-phosphate dehy-
drogenase. (C) Expression of c-jun mRNA during liver develop-
ment. The amount of c-jun mRNA was estimated by quantitative
RT-PCR in wild-type mouse livers of different age (E12.5-adult).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
was estimated as control.Eferl et al. c-Jun in Liver and Heart Development 1055
et al., 1990), showed no significantly deregulated expres-
sion levels in E12.5 livers. One explanation is that at
E12.5, when these analyses were performed, c-jun is ex-
pressed at a very low level (3 3 104 copies per 0.1 mg
RNA) in the liver (Fig. 3 C), and there is an up to three-
fold induction of c-jun in the liver at E13.5-E15.5 (Fig. 3
C), which coincides with the observed apoptosis of hepato-
blasts and erythroid cells as well as the death of c-jun2/2
fetuses. This indicates that c-Jun gains significance in the
liver around E13.5 possibly by exerting functions that are
not essential in earlier phases of fetal development.
ES Cells Lacking c-jun Contribute to the Liver of 
Young but Not Adult Chimeric Mice
Previous studies of chimeric mice that were generated by
injection of ES cells lacking c-jun into wild-type mouse
blastocysts showed that the ES cells contributed to all tis-
sues except to the liver (Hilberg et al., 1993), suggesting
that in the absence of c-Jun no mature hepatocytes can be
generated. However, the morphologic as well as molecular
characterization of liver differentiation and function re-
vealed no striking differences between c-jun1/1 and c-jun2/2
fetuses up to E12.5 (Figs. 1 and 3), which poses the
question up to which developmental stage c-jun2/2 hepa-
toblasts are able to survive and differentiate properly
in chimeric mice. Analysis of c-jun2/2 ES cell contribution
in E14.5-E17.5 chimeric mouse livers was performed in
short-term fetal liver cell cultures. A short culturing period
of the fetal livers allowed us to remove most of the he-
matopoietic cells, which adhere much less efficiently to the
culture dishes than hepatoblasts. In these cultures similar
amounts of c-jun1/1 and c-jun2/2 hepatoblasts were de-
tected by GPI assay (Fig. 4 A). ES cell derivatives lacking
c-jun were also present in chimeric mouse livers at several
weeks after birth (Fig. 4 A). Detailed analysis of the vari-
ous tissues from an 8-wk-old chimeric mouse by PCR
showed substantial contribution of c-jun2/2 cells to the
liver cell mass (Fig. 4 B). These c-jun2/2 cells were present
among the hepatocyte cell population, which was isolated
and enriched by collagenase liver perfusion, ensuring that
the c-jun2/2 cells did not reflect nonparenchymal cells, like
sinusoidal endothelial or Kupffer cells. Moreover, bile
duct epithelial cells were analyzed after enrichment by mi-
crodissection. Since we found substantial contribution of
c-jun2/2 cells to bile duct epithelia, the absence of c-Jun
has no obvious adverse effect on the differentiation of
hepatoblasts into the hepatocytic or the bile duct epithelial
lineage. There was, however, a tendency of continuous
loss of c-jun2/2 hepatocytes in older chimeric mice. c-jun2/2
hepatocytes were detectable up to 8 wk after birth but not
in 3-mo-old or older mice. This points to an imbalance in
the regulation of hepatocyte cell turnover in adult mice in
that c-jun2/2 hepatocytes have either a proliferation or a
survival disadvantage over wild-type hepatocytes.
Figure 4. Contribution of
c-jun2/2 ES cells to tissues of
chimeric mice. (A) Glucose
phosphate isomerase (GPI)
analysis of chimeric mice
during fetal (E13.5–E15.5)
and postnatal development
(1–8 wk). The chimerism was
determined by densitometric
analysis of the GPI-1a (de-
rived from c-jun2/2 ES cells)
and the GPI-1b isoforms (de-
rived from the wild-type
C57BL/6 blastocysts) on a
cellugel. Black bars repre-
sent the amount (%) of
c-jun2/2 cells in fetal hepato-
blasts and postnatal livers.
Gray bars represent the rela-
tive contribution of c-jun2/2
cells to the fetus or the skin
as indicator of average chi-
merism. Each pair of black
and gray bars are data from
one chimeric animal (n.d.; no
c-jun2/2 cells were detect-
able). Presence of c-jun2/2
hepatoblasts during fetal development was analyzed in short-term cultures of fetal liver cells and average chimerism was determined in
the residual fetus (after removal of the liver). During postnatal development, GPI analysis was directly performed on liver tissue and
coat chimerism was assessed by estimation of the coat colors (agouti versus black fur). (B) PCR analysis of c-jun2/2 ES cell contribution
to tissues of an 8-wk-old chimeric mouse. c-jun1/1 and c-jun2/2 alleles were competitively amplified by PCR from DNA of the indicated
tissues (band positions on the right). Hepatocytes were isolated by collagenase perfusion. Bile ducts were microdissected under a ste-
reomicroscope from methylene blue-stained frozen liver sections. Note that at 8 wk of postnatal development c-jun2/2 cells are present in
the liver and among purified hepatocytes. s. intestine, small intestine; l. intestine, large intestine; sal. glands, salivary glands.The Journal of Cell Biology, Volume 145, 1999 1056
Increased Apoptosis and Reduced Cell Growth of
c-jun2/2 Fetal Hepatocytes In Vitro
A possible impact of the loss of c-Jun on hepatocyte cell
turnover, namely, on proliferation capacity and apoptotic
rate, was analyzed in primary cell cultures of E12.5 c-jun1/1
and c-jun2/2 livers. The purity control of these cultures
by immunohistochemical detection of keratin expression
showed presence of .95% keratin positive cells in c-jun1/1
as well as in c-jun2/2 cultures (data not shown). The
growth rates and the achieved cell densities were mark-
edly reduced in c-jun2/2 cultures (Fig. 5, A and B). Simul-
taneous staining of S-phase and apoptotic cells by com-
bined [3H]thymidine incorporation and TUNEL reaction
revealed approximately four times increased apoptosis of
c-jun2/2 hepatoblasts (Fig. 5, C–E). Concomitant with the
increase in the number of apoptotic cells the number of
S-phase cells was decreased to z50%. Analysis of fibro-
blast cultures established in parallel from E12.5 fetuses
yielded essentially similar results. These findings show that
c-Jun is an important proliferation regulator of hepato-
blasts and fibroblasts, and that in addition to the reduced
mitotic capacity the increase in apoptotic rates is a major
factor contributing to the reduced growth potential of
both cell types. The data obtained in vitro together with
the observation that several c-jun2/2 E13.0 fetuses showed
increased apoptoses of erythroblasts and hepatoblasts in
their livers, point to an essential role of c-Jun in the regula-
tion of apoptosis in a diversity of cell types in vitro and in
vivo.
Lack of c-jun Affects the Development of the Outflow 
Tract in the Fetal Heart
Deregulation of apoptosis in the absence of c-Jun was not
evident at E12.5, whereas at E13.0 an increase of apoptosis
was noted in 42% (8/19) of the c-jun2/2 livers. It appears
that apoptosis of liver cells occurs only shortly before
death of the fetuses and, therefore, can be missed if fetuses
are not examined at the appropriate time point. However,
some of the fetuses died without substantial apoptotic
rates in their livers. Thus, apoptosis of hepatoblasts and
erythroid cells in the livers of c-jun2/2 fetuses cannot ex-
plain fetal lethality in all cases. This prompted us to look
for additional defects in c-jun2/2 fetuses. Histological anal-
ysis of E12.5 fetuses by horizontal serial sections revealed
defective development of the heart in all (19/19) of the in-
vestigated c-jun2/2 fetuses (Fig. 6, A and B). The animals
showed a malformation of the outflow tract with a single
outflow vessel that arose entirely from the right ventricle
resembling the congenital human heart malformation of a
persistent truncus arteriosus (incomplete separation of the
aorta and the pulmonary artery). In addition to this anom-
aly of the outflow tract we found in some animals an ab-
normal remodeling of the aortic arch arteries resulting in a
right-sided aortic arch. Moreover, the wall of the right
ventricle was constantly thinner and the endocardial cush-
ion material of the bulbus arteriosus appeared more prom-
inent in c-Jun knockout mice as compared to wild-type
mice. These alterations could, in principle, also reflect a
delay in heart development rather than a true malforma-
tion. However, a mere developmental delay is very un-
likely since we could analyze two c-jun2/2 fetuses which
survived until E14.5 and had heart defects. These fetuses
showed a malformation of the outflow tract with only one
common outflow vessel that arose from the right ventricle,
had an abnormal positioning of the aortic arch, and re-
Figure 5. Growth of fetal liver cells lacking c-jun. (A and B) Pri-
mary liver cultures from E12.5 c-jun1/1 and c-jun2/2 littermates.
Note the reduced cell number and density in cultures from
c-jun2/2 livers (B). Bars: 100 mm. (C and D) Simultaneous detec-
tion of apoptosis and DNA replication in E12.5 fetal liver cul-
tures. Primary hepatoblasts were stained for apoptotic cells by
TUNEL (open arrowheads) and for cells replicating its DNA by
[3H]thymidine incorporation (filled arrowheads). The number of
apoptotic cells is increased in c-jun2/2 cultures (D) whereas the
number of [3H]thymidine-labeled cells is reduced. (E) Percent-
age of [3H]thymidine-labeled cells (dark bars) and apoptotic cells
(light bars) in E12.5 primary liver cells and corresponding fibro-
blast cultures. Note the three- to fourfold increased apoptosis
and reduced number of [3H]thymidine-labeled cells in c-jun2/2
cultures of primary hepatocytes and fibroblasts. The bars repre-
sent mean values of three to six independent experiments using
separate fetuses for preparation of liver and fibroblast cultures.
The standard deviations are indicated. Bars, 50 mm.Eferl et al. c-Jun in Liver and Heart Development 1057
vealed a wide connection between the left and right ventri-
cle. In contrast, c-jun1/1 E14.5 littermates had a regularly
developed aorta ascendens and pulmonary trunk as well as
showed complete septation of the left and right ventricles
(Fig. 6, C–H).
Since there is a general concept that malformations of
the heart outflow tract are due to neural crest cell defects,
and similar malformations were described in mice defec-
tive in genes necessary for neural crest cell development
or migration (Kirby and Waldo, 1995; Rossant, 1996), we
analyzed possible alterations of the contribution of neural
crest cells to the peritracheal and cardiac mesenchyme.
Neural crest cells were detected by immunohistochemical
staining of Cx 43 (Fig. 7, A–F). The analysis showed that
neural crest cells expressing the marker Cx 43 were
present in c-jun2/2 mice and had properly migrated from
the spinal cord to the mesenchyme surrounding the tra-
chea. There was, however, a difference between wild-type
and c-jun2/2 mice in that fewer Cx 43 positive cells were
detected in the outflow tract of the right ventricle of mu-
tant mice. Although the direct comparison of Cx 43–
expressing cells in wild-type and c-jun2/2 mice is ham-
pered because of the differences in the anatomy of the
outflow tracts, the immunofluorescence data are in good
Figure 6. Impaired heart de-
velopment of c-jun2/2 fetuses.
Corresponding horizontal
sections of E12.5 wild-type
(A) and c-jun2/2 mouse fe-
tuses (B) were stained with
HE. At this stage of develop-
ment, wild-type fetuses show
separation of the aorta (ao)
and the pulmonary trunk
(pt). In c-jun2/2 fetuses (B)
there is a single outflow ves-
sel (arrow) that arises from
the right ventricle. Corre-
sponding horizontal sections
through the hearts of E14.5
wild-type (C, E, and G) and
c-jun2/2 mouse fetuses (D, F,
and H). The sections are ar-
ranged from cranial to caudal
and show three major anom-
alies: (a) persistence of the
right branch of the 4th aortic
arch artery (aa in D), (b)
persistent truncus arteriosus
(pta in F) whereas the wild-
type littermate show com-
plete separation of the aorta
and pulmonary trunk (arrow
in E), and (c) incomplete
septation of the ventricles
(arrow in H). ao, aorta; pt,
pulmonary trunk; rv, right
ventricle; lv, left ventricle; ra,
right atrium; la, left atrium;
aa, aortic arch; tr, trachea;
oe, oesophagus; th, thymus;
pv, pulmonary valve; pta,
persisting truncus arteriosus;
av, aortic valve; vs, ventricu-
lar septum. Bars, 200 mm.The Journal of Cell Biology, Volume 145, 1999 1058
accordance with the observed spectrum of heart malfor-
mations that are typical for a neural crest cell defect.
Discussion
c-jun is one of the earliest genes that is transcribed after
stimulation of cells with growth factors and during tissue
regeneration. A central role of c-Jun in the regulation of
cell proliferation has been underlined by previous findings
with cultured c-jun2/2 fibroblasts that had markedly
reduced proliferation capacities (Hilberg et al., 1993;
Johnson et al., 1993; Schreiber et al., 1999). In vivo, how-
ever, lack of c-Jun did not lead to growth defects in fetuses
but caused mid-gestational lethality that was suggested to
Figure 7. Impaired migra-
tion of neural crest cells to
the outflow tracts of c-jun2/2
fetuses. Corresponding hori-
zontal sections of E12.5 wild-
type (A, C, E, and G) and
c-jun2/2 mouse fetuses (B,
D, F, and H) were analyzed
for the presence of neural
crest cells by double-label
immunofluorescence micros-
copy using a monoclonal
mouse antibody against the
neural crest cell protein Cx
43 (green) and polyclonal
antibodies against desmin
(red). The micrographs show
corresponding sections of
c-jun1/1 (A, C, E, and G)
and  c-jun2/2 (B, D, F, and H)
littermates (two c-jun1/1, one
c-jun1/2, and four c-jun2/2 fe-
tuses were analyzed). Cx 43
positive cells were visible in
the outflow tract of wild-type
(arrows in A) but not in
c-jun2/2 fetuses (B). In con-
trast to the outflow tract, no
differences in Cx 43 immu-
noreactivity were found be-
tween wild-type and c-jun2/2
fetuses in the peritracheal
mesenchyme (arrows in C
and D) and the mesenchyme
in vicinity of the spinal cord
(arrows in E and F). For con-
trol, Cx 43 immunoreactivity
is shown in the trabeculae
carneae of the ventricles (G
and H). Note the thinner wall
of the ventricles in c-jun2/2
hearts (H). pt, pulmonary
trunk; ta, truncus arteriosus;
vw, ventricle wall; tr, trachea;
oe, oesophagus; sc, spinal
cord; tc, trabeculae carneae.
Bars, 50 mm.Eferl et al. c-Jun in Liver and Heart Development 1059
be due to a liver defect (Hilberg et al., 1993). Until E12.5
of fetal development, no obvious liver defects were ob-
served in the absence of c-Jun and the expression levels of
15 different mRNAs were similar in wild-type and c-jun
mutant mice. At E13.0, however, numerous apoptoses
were seen in the liver of c-jun2/2 fetuses and lethality oc-
curred. These alterations coincided with the time of c-jun
mRNA induction in the liver indicating that c-Jun exerts a
specific function in liver development at this stage, and
that in the absence of c-Jun, erythroblasts and hepato-
blasts undergo apoptosis. A cell-autonomous defect as the
primary and only cause of erythroblast apoptosis was
ruled out by the ability of hematopoietic precursor cells
isolated from E12.5 c-jun2/2 livers to fully reconstitute all
hematopoietic lineages in lethally irradiated mice. Thus
apoptoses of erythroblasts in homozygous c-jun deleted
livers cannot be exclusively the consequence of the ab-
sence of c-Jun in erythroblasts themselves, but most likely
involves additional exogenous factors, such as an altered
microenvironment in c-jun2/2 fetal livers, that do not al-
low maintenance of hematopoiesis. This microenviron-
ment that has to be provided by the cells of the fetal liver
is yet poorly characterized. It might resemble the microen-
vironment generated by stromal cells of the bone marrow
in adult animals. Stromal cells secrete a variety of growth
factors that stimulate proliferation and differentiation of
hematopoietic cells as well as protect them from apoptosis.
One of these growth factors is erythropoietin, which is an
essential, and probably the most important survival factor
for erythroid cells. Mice carrying loss of function muta-
tions of erythropoietin or the erythropoietin receptor suf-
fered from anemia and died at around E13.5, revealing nu-
merous apoptoses of erythroid cells in their livers, thus
resembling in part the alterations seen in c-jun knockout
mice (Wu et al., 1995). Because the liver is expected to be
the major site of erythropoietin synthesis during fetal de-
velopment, functional deficiencies in c-jun2/2 livers could
result in reduced erythropoietin levels. However, RT-PCR
results revealed that in E12.5 c-jun2/2 fetuses, the erythro-
poietin mRNA concentrations were not altered, so apop-
toses of erythroid cells cannot be explained by decreased
erythropoietin synthesis. Moreover, a general impairment
of erythropoietin signaling in the absence of c-Jun was
excluded by the reconstitution experiments in which
cells  without functional c-Jun properly differentiated into
erythrocytes. So far, we could not further specify the mecha-
nism that caused apoptosis of erythroblasts in c-jun2/2
mice, and besides deficiencies in erythropoietin, alterations
in the expression or function of a variety of other growth
factors as well as changes in cell–cell and cell–matrix inter-
actions must be considered.
The effect of c-Jun inactivation was not restricted to
erythroid cells but also affected other cell types, such as
hepatoblasts and fibroblasts. Primary liver cell as well as
fibroblast cultures established from E12.5 c-jun2/2 fetuses
and their corresponding wild-type littermates showed
markedly increased apoptotic rates in the absence of
c-Jun. This was surprising, since in contrast to our find-
ings, previous studies reported that overexpression of
c-Jun forced fibroblasts into apoptosis, and functional in-
hibition of c-Jun prevented cell death in some cell types (Es-
tus et al., 1994; Ham et al., 1995; Bossy-Wetzel et al., 1997).
These controversial observations indicate that the role of
c-Jun in apoptosis depends on the cellular context and
mode of treatment. It is interesting that in c-jun2/2 mice no
obvious alteration of apoptosis was noted during fetal de-
velopment until E11.5, whereas primary cell cultures de-
rived from E12.5 c-jun2/2 mice had markedly increased
apoptotic rates. One possible explanation for this differ-
ence between the in vivo and in vitro situation is that apop-
tosis is preferentially triggered under enforced stimulation
of proliferation as it is the case under cell culture condi-
tions. It is possible that the absence of c-Jun modulates the
intracellular signals induced by growth factors so that cells
respond with apoptosis instead of mitosis. In addition to
the alterations in apoptosis, we noted reduced mitotic
rates in primary cultures of c-jun2/2 fibroblasts and hepa-
toblasts. One mechanism by which lack of c-Jun could re-
sult in impaired proliferation was recently shown by
Schreiber et al., 1999. The proliferation defect in c-jun2/2
fibroblast cell lines was found to be p53-dependent, indi-
cating that the alterations of proliferation, and probably
also the increased propensity of cells to undergo apoptosis
may involve p53-dependent pathways.
The altered regulation of cell proliferation and apopto-
sis in the absence of c-Jun could be an explanation for the
occurrence of massive apoptosis of erythroblasts and
hepatoblasts in c-jun2/2 E13.0 fetuses. Moreover, the pro-
liferation defect as well as the increase in apoptosis could
lead to the loss of c-jun2/2 cells in livers of adult chimeric
mice because of a lower capacity of c-jun2/2 hepatocytes
to contribute to the cell turnover. However, it is unlikely
that the deregulation of proliferation and apoptosis is the
only cause of fetal lethality since massive apoptosis was
seen in only 2 livers out of 19 c-jun2/2 fetuses, and we have
analyzed some c-jun2/2 fetuses that had died in utero with-
out showing severe morphological liver alterations.
It is known from other gene knockout mice, that in addi-
tion to the liver, defects in other organ systems, especially
the cardiovascular system, have to be considered as causes
of mid-gestational lethality (Rossant, 1996). Detailed in-
vestigation of hearts of c-jun2/2 fetuses revealed a novel
function for c-Jun in fetal heart development. Lack of
c-Jun led to several anomalies of the heart outflow tracts.
All of the c-jun2/2 fetuses had compared with wild-type lit-
termates anomalies of the aorta ascendens and pulmonary
artery in that in mutant mice there was a single outflow
vessel arising from the right ventricle resembling a truncus
arteriosus persistens. In addition to the outflow tract alter-
ation, some mice showed a right-sided aortic arch. These
anomalies are typical for a neural crest cell defect (Kirby
and Waldo, 1995). It has been shown that the ectomesen-
chymal cells of cardiac neural crest, which extends from
the midotic placode to the caudal limit of somite 3, migrate
into the outflow tract of the heart where they contribute to
the aorticopulmonary septum. Moreover, cardiac neural
crest cells differentiate into smooth muscle cells of the aor-
tic arch and contribute to the stroma of other derivatives
of the pharyngeal arches such as thymus, parathyroid, and
thyroid gland (Kirby and Waldo, 1990). Experimental ab-
lation of neural crest cells in chick embryos led to various
defects of which a persistent truncus arteriosus was a com-
mon denominator. These lesions were always combined
with a ventricular septal defect (Nishibatake et al., 1987).The Journal of Cell Biology, Volume 145, 1999 1060
Furthermore, a right-sided aortic arch or anomalies of the
other great arteries were seen after partial neural crest cell
ablation.
The cardiovascular defects observed by us in c-Jun
knockout mice were almost identical to those found after
neural crest cell ablation in chicken. Similar to the obser-
vations in chicken, a variety of gene mutant mice with im-
paired neural crest cell development showed anomalies of
the outflow tract. For instance, the mouse mutant Splotch,
which harbors a mutation in the homeobox gene pax3, ex-
hibits conotruncal and aortic arch defects (Conway et al.,
1997; for review on mouse mutants with heart defects see
Olson and Srivastava, 1996). In contrast to the situation in
chicken and in the above-mentioned mouse mutant, where
cardiac neural crest cell were either absent or had a gen-
eral defect, we have observed no difference in neural crest
cell distribution in c-jun knockout mice except for a re-
duced number of Cx 43–expressing cells in the outflow
tract of the right ventricle. This observation suggests that
the consequences of c-Jun inactivation primarily affects
neural crest cell function in the heart and does not result
in a general neural crest cell defect. As known from neu-
ral crest cell ablation experiments in animals as well as
from human diseases with a truncus arteriosus persistens
(e.g., DiGeorge syndrome), the malformations are not re-
stricted to the heart but also affect other neural crest cell
derivatives, such as the thymus or parathyroid. In c-jun
mutant fetuses, however, morphologic analysis provided
no evidence for a thymus defect, and thus for a general al-
teration of the cardiac neural crest (Fig. 6, C and D). Nev-
ertheless, the cardiac malformations observed are highly
reminiscent for a disturbance of neural crest function,
which may be restricted to the heart and great vessels.
Moreover, as shown by neural crest cell transplantation
experiments, the mere presence of neural crest cells does
not exclude functional deficiencies (Kirby and Waldo,
1990).
The cardiac malformation of a truncus arteriosus persis-
tens may be a major factor contributing to the lethal phe-
notype. In principle, occurrence of a truncus arteriosus
persistens is compatible with survival because of compen-
sation of the hemodynamic imbalance. This compensation
may not occur in c-jun mutant fetuses and fetal lethality
might be due to pleiotropic defects reflecting the diversity
of functions of c-Jun in development, such as a role in neu-
ral crest cell function, in the maintenance of hepatic he-
matopoiesis and in the regulation of apoptosis.
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